Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00538057 | Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects | PHASE1 | COMPLETED | 16 | — | — | Oct 2, 2007 | Dec 1, 2007 | Aug 4, 2017 | 1 | Australia |
| Arm | Type | Description |
|---|---|---|
| arm 1 | EXPERIMENTAL | study drug |
| Name | Type | Description |
|---|---|---|
| GW685698X & GW642444M | DRUG | study drug |
Inclusion criteria: * Healthy adults aged between 18 and 60 years. * Male subjects or female subjects of non child bearing potential. * Body weight at least 50 kg and BMI within the range of 19-31 kg/m2 inclusive. * No significant abnormality from ECG at screening. * FEV1 at least 90% predicted and...